CClinicalTrials.gg
Sign In
Status unknownNCT05351307Updated Apr 28, 2022

Retinal Vascular Changes in Primary Open Angle Glaucoma Patients

An observational study in Primary Open Angle Glaucoma, sponsored by Sohag University. Status unknown at 1 site in Egypt. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2022-04-28.

Sponsored by Sohag University · Observational

The sponsor has not verified this record recently (last verified Apr 2022), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
100
Ages
18 Years to 60 Years
Sex
All
01

Study summary

the study aims to detect ischemic changes in macula using OCT angiography in primary open angle glaucoma patients correlating with glaucoma staging system II by visual field.

Read the detailed description

Our study will be designed as " prospective non-randomized case - control study" The study will include 100 eyes of 100 participants 50 eyes of normal subjects , non-glaucomatous subjects 50 eyes of 50 patients with POAG To detect ischemic changes in macula using OCT angiography correlating with glaucoma staging system II by visual field.

02

Conditions studied

  • Primary Open Angle Glaucoma
03

In context

Glaucoma

1,818 studies on the registry are indexed under Glaucoma; 231 are open to participants now.

This study's planned enrollment of 100 is close to the median of 103 across 454 observational studies indexed under Glaucoma.

Browse Glaucoma studies →

Lead sponsor

Sohag University is the lead sponsor of 1,183 studies on the registry; 612 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Sampling method
Probability sample

Study population

> 18 years primary open angle glaucoma patients

Inclusion criteria

  • (> 18 years old)

Exclusion criteria

Exclusion Criteria:

  • patients with cataract
  • retinal disorders including: AMD , Macular degeneration , retinal detachment , retinitis pigmentosa , etc .
  • corneal opacites
  • any ocular surgeries
  • patients with systemic disease.
  • patient refusal
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
100 participants (estimated)
Target follow-up
1 Month
Patient registry
Yes

Groups and cohorts

  • POAG patients

    OCT angiography will be performed

  • Normal participants

    OCT angiography will be performed

06

What researchers measure

Primary outcomes

  1. ischemic changes in macula

    Using OCT angiography to detect ischemic changes in macula

    Time frame: Through one year

07

Study locations

1 site
  • Sohag University hospitals
    Sohag, Egypt
    • Osama R Elshereif, Professor · Contact
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 28, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05351307
Lead sponsor
Sohag University
Responsible party
Marwa Hamza Ali (Principal investigator, Sohag University) — Principal investigator
First posted
Apr 28, 2022
Start date
Jun 1, 2022 (estimated)
Primary completion
Apr 1, 2023 (estimated)
Completion
Jun 1, 2023 (estimated)
Last update
Apr 28, 2022

Study contacts

Marwa Hamza, Resident
Contact
Marwahamza12@yahoo.com
01018421051
Ismail Moussa Abd-Elatif, Professor
Contact
Mohamed Iqbal Hafez, Assist prof
study director · Supervisor
Hany Mahmoud Abdel Hamid, Lecturer
study director · Supervisor

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Glaucoma→

Other studies from this sponsor

Sohag University

Start the discussion